XACT Robotics Introduces World’s First Robotic System with Image-based Planning and Navigation, Operated Hands-Free
XACT Robotics® is a privately-owned enterprise committed to propelling radiology to new heights through the creation of groundbreaking, hands-free robotic solutions that optimize targeting precision, efficiency, and consistency during percutaneous radiology procedures. Founded in 2013 by Harel Gadot, a distinguished entrepreneur within the MedTech robotics field, XACT represents a paradigm shift in image-guided percutaneous interventions.
Collaboration, perseverance, and absolute accountability serve as the bedrock values of XACT, which operates as a tight-knit family to motivate and equip its members to design and implement pioneering technologies that enhance patient outcomes.
As per the company’s assertion, its leadership is constituted of luminaries in the domains of startups, robotics, and cutting-edge technologies, who possess a profound acumen, extensive experience, and multifarious proficiencies essential to thrive in the realm of robotics. The XACT ACE™ Robotic System stands unparalleled in the world as the sole hands-free robotic technology that integrates advanced image-based procedure planning and navigation, robotic instrument insertion, and non-linear steering capabilities.
Why go for XACT ACE?
Accuracy
The XACT ACE™ Robotic system is ingeniously crafted to facilitate a vast gamut of percutaneous procedures, ranging from biopsies and ablations to drug delivery, by furnishing hands-free targeting with unparalleled precision and command. The system is bolstered by a blend of cutting-edge image-based planning and navigation, as well as automated instrument insertion and non-linear steering capabilities, which synergize to achieve an extraordinary level of accuracy, with an average deviation of less than 3mm from instrument tip to target. Furthermore, the ACE’s non-linear steering proficiency empowers medical professionals to access elusive sites, even when the target shifts during the procedure due to various factors such as instrument insertion, patient motion, or respiratory dynamics.
Consistency
ACE possesses the capacity to augment patient outcomes and expedite procedural timelines by optimizing accuracy. Through its dependable and replicable execution of a single insertion to target, ACE mitigates the demand for instrument reinsertions, thereby reducing the intricacy, delays, and duration of procedures. Clinical investigations have substantiated that ACE’s hands-free robotic skin-to-target time averages less than 8.5 minutes, culminating in more foreseeable procedural durations that optimize the efficient utilization of healthcare resources and staff.
Efficiency
The XACT ACE™ Robotic System has been engineered to be compact and portable, enabling healthcare providers to effectively address diverse patient care requirements across numerous body regions. Its small footprint allows for swift setup and ease of use in patients without necessitating a specialized or dedicated operating environment. The system’s versatility is reflected in its ability to perform an array of percutaneous procedures, including ablation, biopsy, and drug delivery, while remaining compatible with multiple imaging modalities. It can also precisely deliver a range of instruments to a specific target, making it an ideal solution for a variety of clinical scenarios.
For your information (News)
Lahey Hospital & Medical Center has recently acquired the XACT ACE™ Robotic System for use in its Interventional Radiology service, showcasing the hospital’s dedication to providing the highest quality of care to its patients. This state-of-the-art technology combines advanced image-based planning and navigation with hands-free robotic instrument insertion and steering capabilities, enabling radiologists to perform percutaneous procedures with unparalleled precision, consistency, and efficiency. With the XACT ACE™ Robotic System, physicians can accurately target challenging-to-reach locations and deep-seated organs, ultimately leading to improved patient outcomes. Dr. Christoph Wald, Chair of Radiology at Lahey Hospital & Medical Center, stated that this investment in cutting-edge technology aligns with the hospital’s mission to deliver the most exceptional healthcare available. As the first hospital in the US to offer robotic percutaneous procedures with the XACT ACE™ Robotic System, Lahey Hospital & Medical Center is a pioneer in the field of interventional radiology.
The XACT ACE Robotic system is a versatile device that can be used with different imaging modalities and can precisely deliver various medical instruments to the targeted area. Its compact design and mobility make it applicable to a broad range of medical procedures across different anatomical locations.
Dr. Sebastian Flacke, the Chief of Interventional Radiology at Lahey Hospital & Medical Center, mentioned that they have actively participated in clinical studies to validate the efficacy of the XACT Robotic System and have contributed to its design for better clinical outcomes. Harel Gadot, Executive Chairman and President of XACT Robotics, expressed enthusiasm about the recent acquisition of the system by Lahey Hospital and Medical Center, which provides access to its advanced technology and benefits. He believes that the XACT ACE System will enhance the standards of percutaneous radiology, offering improved clinical, technical, and economic value to healthcare providers and their patients.
Shai Meltzer, Chief Executive Officer
Shai Meltzer is the CEO of XACT Robotics, a medical device company that he co-founded in 2016. He has over 20 years of experience in the medical device industry, with a proven track record of developing and commercializing innovative medical technologies. Before founding XACT Robotics, Meltzer served as the CEO of Deep Breeze, a medical device company that developed a non-invasive imaging system for the diagnosis of respiratory diseases. He also held various leadership positions at Given Imaging, a company that developed innovative gastrointestinal diagnostic products.
Meltzer holds a B.Sc. in Electrical Engineering from Tel Aviv University and an M.Sc. in Biomedical Engineering from the Technion – Israel Institute of Technology. As CEO of XACT Robotics, Meltzer is responsible for leading the company’s overall strategy and operations, overseeing the development and commercialization of the XACT Robotics system, and working closely with the company’s team of engineers and medical professionals to bring the system to market and improve patient outcomes.
